British Patient Capital backs SV Health Investors Impact Medicine Fund

20 July 2020 – British Patient Capital has invested USD65 million in SV Health Investors’s USD265 million fund, SV7 Impact Medicine Fund (IMF), which is dedicated to investing in biotech companies.

Read full article